# VANI (Vivani Medical, Inc.) - SEC EDGAR Financial Statements

> Vivani Medical, Inc. reported $0 in revenue and a net loss of $27.03M for the fiscal year ended December 31, 2025.

- Canonical: https://convexityos.com/fundamentals/VANI
- Markdown: https://convexityos.com/fundamentals/VANI.md
- SEC CIK: 0001266806
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001266806&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | Dec 31, 2025 |
| Operating Income | FY 2025 | -$28.03M | Operating profit |
| Net Income | FY 2025 | -$27.03M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.30 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$25.72M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $14.59M | Total debt: $17.41M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | -- | -- | -- | -- | $3.38M | $6.90M | $7.96M | $4.00M |
| Cost of Revenue | -- | -- | -- | -- | $130K | $500K | $2.15M | $4.89M | $5.12M | $10.08M |
| **Gross Profit** | -- | -- | -- | -- | $130K | $500K | $1.23M | $2.01M | $2.85M | -$6.09M |
| Research & Development | $18.13M | $15.74M | $16.97M | $14.17M | $11.00M | $4.84M | $13.14M | $10.01M | $7.89M | $5.35M |
| Selling, General & Admin | -- | -- | -- | -- | -- | $6.64M | $15.33M | $22.03M | $20.50M | $19.07M |
| Total Operating Expenses | $27.56M | $24.68M | $26.96M | $21.24M | $13.32M | $15.40M | $35.18M | $37.19M | $31.46M | $27.12M |
| **Operating Income** | -$27.56M | -$24.68M | -$26.96M | -$21.24M | -$13.32M | -$14.90M | -$33.95M | -$35.18M | -$28.61M | -$33.21M |
| **EBITDA** | -$27.13M | -$24.28M | -$26.61M | -$20.86M | -$12.98M | -$14.73M | -$33.56M | -$34.74M | -$28.15M | -$32.78M |
| Interest Income | -- | -- | -- | $475K | $550K | $16K | $362K | $86K | $93K | $31K |
| Income Before Tax | -$26.61M | -$23.49M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | -- | $2.0K | -- | -- | -- | -- | $0 | $0 | -- | -- |
| **Net Income** | -$26.61M | -$23.49M | -$25.65M | -$13.89M | -$12.77M | -$14.88M | -$33.59M | -$35.09M | -$28.52M | -$33.18M |
| Basic EPS | -$0.43 | -$0.43 | -$0.50 | -- | -$0.27 | -$0.72 | -$2.28 | -$0.53 | -$0.07 | -$0.10 |
| **Diluted EPS** | -$0.43 | -$0.43 | -$0.50 | -- | -$0.27 | -$0.72 | -$2.28 | -$0.53 | -$0.07 | -$0.10 |
| Basic Shares Outstanding | 62.4M | 55.0M | 50.9K | -- | 32.8M | 20.6M | 14.7M | 66.4M | 433.2M | 316.4M |
| Diluted Shares Outstanding | 62.4M | 55.0M | 50.9K | -- | 32.8M | 20.6M | 14.7M | 66.4M | 433.2M | 316.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | $0 | $0 | -- |
| Research & Development | $5.02M | $4.46M | $4.39M | $4.63M | $4.52M | $4.76M | $4.22M | $4.30M |
| Total Operating Expenses | $7.53M | $6.87M | $6.82M | $6.81M | $6.72M | $7.46M | $6.56M | $6.46M |
| **Operating Income** | -$7.53M | -$6.87M | -$6.82M | -$6.81M | -$6.72M | -$7.46M | -$6.56M | -$6.46M |
| **EBITDA** | -$7.40M | -$6.75M | -$6.69M | -$6.70M | -$6.62M | -$7.36M | -$6.46M | -$6.37M |
| **Net Income** | -$7.25M | -$6.37M | -$6.78M | -$6.63M | -$6.53M | -$7.14M | -$6.30M | -$6.05M |
| Basic EPS | -$0.08 | -$0.07 | -$0.08 | -- | -$0.11 | -$0.12 | -$0.11 | -- |
| **Diluted EPS** | -$0.08 | -$0.07 | -$0.08 | -- | -$0.11 | -$0.12 | -$0.11 | -- |
| Basic Shares Outstanding | 90.1M | 87.1M | 81.3M | -- | 59.7M | 59.2M | 59.2M | -- |
| Diluted Shares Outstanding | 90.1M | 87.1M | 81.3M | -- | 59.7M | 59.2M | 59.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $16.23M | $18.35M | $20.65M | $45.08M | $2.18M | $2.08M | $11.33M | $4.47M | $7.84M | $10.88M |
| **Cash & Short-Term Investments** | $16.23M | $18.35M | $20.65M | $45.08M | $2.18M | $2.08M | $11.33M | $4.47M | $7.84M | $10.88M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $455K | $504K | $1.83M | $274K |
| Inventory | -- | -- | -- | -- | -- | -- | $1.03M | $3.25M | $2.70M | $3.42M |
| **Total Current Assets** | $17.90M | $20.44M | $23.06M | $47.53M | $2.47M | $4.27M | $13.11M | $9.62M | $13.16M | $15.28M |
| Property, Plant & Equipment, Net | $2.88M | $1.69M | $1.73M | $1.18M | $1.17M | $174K | $1.12M | $1.02M | $1.30M | $1.49M |
| Other Non-Current Assets | $1.34M | $1.34M | $1.34M | $1.37M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $21.50M | $21.12M | $22.73M | $3.60M | $2.98M | $191K | $3.49M | $1.06M | $1.33M | $1.53M |
| **Total Assets** | $39.39M | $41.56M | $45.80M | $51.13M | $5.45M | $4.46M | $16.60M | $10.68M | $14.50M | $16.81M |
| Accounts Payable | $1.03M | $817K | $542K | $1.18M | $281K | $486K | $1.09M | $1.30M | $752K | $1.16M |
| Short-Term Debt | -- | -- | -- | -- | -- | $2.20M | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | $335K | $335K | $335K | $167K | $48K | $85K |
| **Total Current Liabilities** | $6.60M | $5.99M | $5.72M | $6.82M | $2.09M | $5.13M | $6.96M | $7.60M | $6.62M | $5.66M |
| **Total Non-Current Liabilities** | $17.06M | $17.96M | $19.31M | $0 | $902K | $0 | $2.37M | $0 | $0 | $0 |
| **Total Liabilities** | $23.66M | $23.95M | $25.04M | $6.82M | $2.99M | $5.13M | $9.32M | $7.60M | $6.62M | $5.66M |
| **Total Debt (incl. Leases)** | $18.86M | $19.31M | $20.70M | $955K | $1.81M | $2.20M | $2.60M | -- | -- | -- |
| Common Stock | $8.0K | $6.0K | $5.0K | $5.0K | $54.65M | $270.1M | $264.0M | $229.0M | $202.2M | $186.8M |
| Retained Earnings | -$148.5M | -$121.9M | -$98.44M | -$72.79M | -$58.90M | -$319.7M | -$304.8M | -$269.5M | -$234.4M | -$205.9M |
| Accumulated Other Comp. Income | $30K | $48K | $140K | $35K | -$379K | -$448K | -$562K | -$575K | -$572K | -$608K |
| **Total Stockholders' Equity** | $15.73M | $17.61M | $20.76M | $44.31M | $2.46M | $1.95M | $7.28M | $3.08M | $7.88M | $11.15M |
| Total Equity | $15.73M | $17.61M | $20.76M | $44.31M | $2.46M | $1.95M | $7.28M | $3.08M | $7.88M | $11.15M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14.59M | $19.89M | $19.75M | $16.23M | $2.63M | $6.79M | $13.01M | $18.35M |
| **Cash & Short-Term Investments** | $14.59M | $19.89M | $19.75M | $16.23M | $2.63M | $6.79M | $13.01M | $18.35M |
| Accounts Receivable, Net | -- | -- | $12K | -- | -- | -- | -- | -- |
| **Total Current Assets** | $15.83M | $21.64M | $21.55M | $17.90M | $4.17M | $8.71M | $14.85M | $20.44M |
| Property, Plant & Equipment, Net | $2.76M | $2.85M | $2.75M | $2.88M | $2.73M | $1.58M | $1.61M | $1.69M |
| Other Non-Current Assets | $892K | $892K | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M |
| **Total Non-Current Assets** | $19.48M | $20.00M | $20.80M | $21.50M | $20.87M | $20.19M | $20.60M | $21.12M |
| **Total Assets** | $35.31M | $41.64M | $42.35M | $39.39M | $25.05M | $28.91M | $35.45M | $41.56M |
| Accounts Payable | $1.21M | $1.20M | $1.47M | $1.03M | $1.43M | $1.76M | $1.00M | $817K |
| **Total Current Liabilities** | $6.58M | $6.66M | $6.78M | $6.60M | $6.83M | $6.72M | $6.20M | $5.99M |
| **Total Non-Current Liabilities** | $15.51M | $16.01M | $16.49M | $17.06M | $16.91M | $17.28M | $17.63M | $17.96M |
| **Total Liabilities** | $22.09M | $22.67M | $23.27M | $23.66M | $23.74M | $24.00M | $23.83M | $23.95M |
| **Total Debt (incl. Leases)** | $17.41M | $17.86M | $18.27M | $18.86M | $18.29M | $18.62M | $18.94M | $19.31M |
| Common Stock | $9.0K | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K |
| Retained Earnings | -$168.9M | -$161.7M | -$155.3M | -$148.5M | -$141.9M | -$135.4M | -$128.2M | -$121.9M |
| Accumulated Other Comp. Income | $32K | $32K | $32K | $30K | $141K | $81K | $42K | $48K |
| **Total Stockholders' Equity** | $13.22M | $18.97M | $19.09M | $15.73M | $1.31M | $4.91M | $11.62M | $17.61M |
| Total Equity | $13.22M | $18.97M | $19.09M | $15.73M | $1.31M | $4.91M | $11.62M | $17.61M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26.61M | -$23.49M | -$25.65M | -$13.89M | -$12.77M | -$14.88M | -$33.59M | -$35.09M | -$28.52M | -$33.18M |
| Depreciation & Amortization | $424K | $400K | $357K | $381K | $345K | $164K | $397K | $435K | $457K | $432K |
| Stock-Based Compensation | $1.48M | $1.61M | $1.86M | $1.30M | $1.67M | $421K | $2.92M | $3.59M | $3.78M | $3.37M |
| Change in Receivables | -- | -- | -- | -- | -- | $461K | $48K | $1.22M | -$1.41M | $955K |
| Change in Inventory | -- | -- | -- | -- | -- | $529K | -$347K | -$1.18M | $3.87M | $10K |
| Change in Payables | -$222K | $248K | -$602K | -$1.94M | $13K | -$1.05M | -$213K | $554K | -$419K | $446K |
| **Operating Cash Flow** | -$24.32M | -$20.79M | -$23.70M | -$18.79M | -$10.95M | -$16.82M | -$27.63M | -$29.81M | -$23.95M | -$25.07M |
| Capital Expenditure | -$1.17M | -$556K | -$887K | -$338K | -$572K | -$330K | -$493K | -$163K | -$265K | -$490K |
| **Free Cash Flow** | -$25.49M | -$21.34M | -$24.59M | -$19.12M | -$11.52M | -$17.15M | -$28.12M | -$29.97M | -$24.21M | -$25.56M |
| **Investing Cash Flow** | -$1.17M | -$556K | -$887K | -$338K | -$572K | $68K | -$493K | -$163K | -$265K | -$490K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $25.94M | $20.77M | $19.48M |
| **Financing Cash Flow** | $23.27M | $19.05M | $133K | $63.39M | $11.62M | $8.60M | $34.99M | $26.60M | $21.17M | $20.45M |
| **Net Change in Cash** | -$2.12M | -$2.30M | -$24.45M | $44.26M | $97K | -$8.15M | $6.86M | -$3.37M | -$3.04M | -$5.08M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.25M | -$6.37M | -$6.78M | -$6.63M | -$6.53M | -$7.14M | -$6.30M | -$6.05M |
| Depreciation & Amortization | $129K | $128K | $130K | $115K | $105K | $102K | $102K | $89K |
| Stock-Based Compensation | $378K | $313K | $312K | $467K | $276K | $391K | $350K | $402K |
| Change in Payables | -$27K | -$397K | $433K | -$396K | -$759K | $758K | $175K | -$26K |
| **Operating Cash Flow** | -$6.39M | -$6.04M | -$6.20M | -$6.72M | -$6.35M | -$6.09M | -$5.16M | -$5.81M |
| Capital Expenditure | $0 | -$99K | -$3.0K | -$274K | -$823K | -$71K | -$5.0K | -$296K |
| **Free Cash Flow** | -$6.39M | -$6.13M | -$6.20M | -$6.99M | -$7.17M | -$6.16M | -$5.17M | -$6.11M |
| **Investing Cash Flow** | $0 | -$99K | -$3.0K | -$274K | -$823K | -$71K | -$5.0K | -$296K |
| **Financing Cash Flow** | $1.09M | $5.83M | $9.71M | $20.59M | $2.95M | -$95K | -$170K | $4.83M |
| **Net Change in Cash** | -$5.30M | -$301K | $3.52M | $13.60M | -$4.17M | -$6.21M | -$5.34M | -$1.29M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | 36.3% | 29.1% | 35.7% | -152.3% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -1004.9% | -509.9% | -359.2% | -830.2% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -994.1% | -508.6% | -358.1% | -829.5% |
| Return on Equity (ROE) | -169.2% | -133.4% | -123.6% | -31.3% | -518.2% | -763.1% | -461.7% | -1137.9% | -361.8% | -297.6% |
| Return on Assets (ROA) | -67.5% | -56.5% | -56.0% | -27.2% | -234.2% | -333.6% | -202.4% | -328.5% | -196.7% | -197.4% |
| Current Ratio | 2.71x | 3.41x | 4.03x | 6.97x | 1.18x | 0.83x | 1.88x | 1.27x | 1.99x | 2.70x |
| Quick Ratio | 2.46x | 3.07x | 3.61x | 6.61x | 1.04x | 0.41x | 1.74x | 0.84x | 1.58x | 2.10x |
| Debt to Equity | 1.20x | 1.10x | 1.00x | 0.02x | 0.74x | 1.13x | 0.36x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -51.0% | -13.4% | +99.1% | -55.1% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -74.0% | -59.3% | -38.9% | -29.5% | -- | -266.6% |
| 5Y Revenue / Share Growth | -- | -100.0% | -- | -- | -- | -- | -98.6% | -98.8% | -- | -- |
| 10Y Revenue / Share Growth | -100.0% | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -204.5% | -138.7% | -141.9% | -169.2% | -1988.2% | -520.1% | -204.3% | -133.4% |
| Return on Assets (ROA) | -76.6% | -63.2% | -64.0% | -67.5% | -103.9% | -88.3% | -67.0% | -56.5% |
| Current Ratio | 2.40x | 3.25x | 3.18x | 2.71x | 0.61x | 1.30x | 2.40x | 3.41x |
| Quick Ratio | 2.22x | 2.99x | 2.92x | 2.46x | 0.38x | 1.01x | 2.10x | 3.07x |
| Debt to Equity | 1.32x | 0.94x | 0.96x | 1.20x | 13.98x | 3.79x | 1.63x | 1.10x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
